This is the quietest field in the package insert. Unlike efficacy or dosage, it does not directly move a clinical decision; unlike a boxed warning, it does not stop the reader in red type. There is a nonproprietary name, a chemical name, a molecular formula, a structural diagram. For a radiopharmaceutical, nuclear physical properties are added. In short, this field states, as plain objective fact, what the drug is as a chemical entity. Precisely because it is unglamorous, whether it is written correctly determines the foundation of trust for the whole document.
This field answers one thing only: "chemically, what is this drug?" Whether it works, and how to use it, belong to other fields. Here the identity itself is presented, without interpretation or persuasion.
01Why "identity" deserves its own field
If the identity of the active ingredient wavers, every record built upon it — pharmacology, pharmacokinetics, safety — floats free. Clinical data become meaningful only once it is fixed which molecule is being discussed. This field is therefore like the foundation piling that supports the building. It never shows in the facade, but if it is bent, every floor above tilts.
In the spirit of the foreword, the electronic package insert is the original record that speaks for the product, existing to complement the reader's judgment. Complementation presupposes that the subject is unambiguously fixed. Pinning the molecule to a single point through nonproprietary name and chemical structure is this field's role — the "fixing of the subject" for all that follows.
02The listed elements and their differing roles
Even among "names," the nonproprietary name and the chemical name serve different functions. Settling for one of them lets information fail to reach some classes of reader.
| Element | What it carries | What it means to the reader |
|---|---|---|
| Nonproprietary name | An identifier valid worldwide and domestically | Common language for prescribing, dispensing, literature search; points to the molecule without depending on a brand |
| Chemical name | A strict definition based on naming rules | Specifies, unambiguously, stereochemistry and the salt/hydrate form |
| Molecular formula | A summary of constituent atoms and counts | Confirms molecular weight and elemental composition; a clue to salt or hydrate |
| Structural formula | A drawing of atomic connectivity and geometry | Skeletal comparison with related drugs; starting point for metabolism and interaction |
| Nuclear physical properties | For radioactive substances only: half-life, type of radiation, etc. | Bears directly on exposure, decay, and preparation timing |
Because each element covers a different range, identity becomes three-dimensional only when they are present together. A name alone drops the salt or hydrate distinction; a structure alone is not the shared language of search and prescription.
03The nonproprietary name — the molecule's address, independent of the brand
A brand name is the seller's word; the nonproprietary name is the molecule's own address. Even when several generics appear, even when foreign literature is consulted, the same name reaches the same molecule. This field places the nonproprietary name first so that the reader is handed, at the outset, the entrance for connecting the document to outside knowledge — textbooks, papers, the inserts of other drugs.
Leave no variation in notation
Where kana, English, and romanized forms correspond, and where alternative or former names exist, leaving variation unresolved invites misreading the molecule as something else. The foreword warns not only against falsehood. A misleading manner of writing is to be avoided with equal weight. Notation of names is where that prevention pays off most cheaply.
04Chemical name and structure — fixing it to one point
The chemical name is written in the shared grammar of naming rules. For that reason the same molecule arrives at the same name the world over, without confusing salt, ester, hydrate, or optical isomer. The structural formula renders this as a picture, showing at a glance the geometry and bonding that prose conveys poorly.
When the active ingredient is present as a salt or hydrate, leaving ambiguous whether a quantity refers to the free base (acid) or to the salt breaks consistency with the later content and dosage statements. Fixing the form at the stage of chemical name and molecular formula protects the arithmetic of the whole document.
The structure underpins later understanding
Sites of metabolism, interactions, and stability toward light and heat all reduce, in the end, to structure. Showing the skeleton accurately here gives the reader a foothold when reading the pharmacokinetics or compatibility sections. The structural formula is not ornament; it is the reference point that makes the later clinical text intelligible.
05Nuclear physical properties of radiopharmaceuticals
For radioactive substances only, nuclear physical properties — half-life, type and energy of radiation, mode of decay — are stated. This follows from the special circumstance that such drugs cannot be handled safely on chemical identity alone.
- Half-life governs the timing from preparation to administration or imaging, and the estimate of residual radioactivity.
- Type and energy of radiation set the premises for exposure control and shielding.
- Mode of decay bears on the nuclides produced and the choice of measurement method.
What is unnecessary for ordinary drugs is added for radioactive substances. The recording of identity is not uniform; it places, without excess or shortfall, the facts required by the nature of the drug. That principle shows itself here.
06Do not create "same fact, different appearance"
The trap of scientific writing is less in stating falsehood than in selecting facts to manufacture an impression. Even in the identity field, leaning a name toward the brand, or omitting an unflattering alternative name, can make the same molecule wear a different face.
A fictional example. One document presents an ingredient with its nonproprietary name and full chemical name; another gives only a colloquial label. Neither is a lie, yet the latter strips the reader of the means to cross-check against other literature. In an objective field, removing the possibility of verification is itself a breach of neutrality.
So what is asked of the writer here is not clever expression but exhaustive fixing: a name whose source can be traced, a structure that cannot be mistaken, a molecular formula settled down to its form (salt, hydrate). With these in place, the reader can verify independently.
07Where the text is silent, govern by the higher norm
The required elements are set, but no provision dictates every detail of notation or the precision of a diagram. The spirit of the foreword asks that, exactly in the unwritten territory, one govern oneself by the higher norm — accurate, fair, not misleading. In the identity field this comes down to a single point: keep the molecule in a state where the reader can independently identify and verify it. The writer's discretion is used not to arrange impressions but to raise verifiability.
This field lacks flourish, but in exchange it fixes the subject of the entire document. Nonproprietary name, chemical name, molecular formula, structural formula — and, for a radioactive substance, nuclear physical properties — each covering a different range, together pin the molecule to a single point.
What is required is not expression but fixing: traceable to its source, impossible to mistake, settled down to its form. Keeping the molecule in a state the reader can cross-check unaided is what neutrality means in an objective field, and it is the foundation supporting every record that follows.